Journal Information 

The bilingual publication Biomedical and Biopharmaceutical Research / Investigação Biomédica e Biofarmacêutica (BBR|IBB) is an international peer-reviewed scientific publication, created over twenty years ago with the aim of promoting the progress of society through health-related knowledge in Portuguese-speaking countries around the world. BBR | IBB is distinguished with the High Patronage of the CPLP (Community of Portuguese-speaking Countries).

Along the way, BBR | IBB has consolidated its role as a platform of opportunities (for publication, knowledge sharing, interconnection), especially among young researchers in the Portuguese-speaking community and beyond, gaining visibility on the international stage. BBR | IBB is not exclusive to Portuguese-speaking authors. Many of the challenges faced in the Portuguese-speaking world are shared by the rest of the world.

In this sense, responding to the increasing number of requests we have been receiving, BBR | IBB is now entering a new cycle of development, dividing itself into three more specialised publications, always within the ‘biomedical and biopharmaceutical’ scope that gave rise to it:
BBR Global Health and Well-being
BBR Pharmacology and Technology
BBR Physiology and Translational Medicine

Each of these publications will allow for a better focus on the topics it covers (see below), while continuing to focus as a whole on environmental, social, behavioural, technological and political perspectives to promote human health and prevent disease in individuals and their communities.

BBR | IBB is an independent, open-access publication, free for readers and authors in the Portuguese-speaking community, focused on high-quality research, promoting diversity, equity and equality, and guided by the highest ethical standards in human health research.

Scope

BBR | IBB is dedicated to fundamental/integrative and translational research, serving as a platform for the exchange of knowledge through the publication of original articles, reviews, case studies, and other forms of scientific dissemination. BBR | IBB is divided into the following:

BBR One Health and Wellbeing
focused on, but not limited to, Behaviour, Lifestyles, (Physical) Activity and Wellbeing, Health (public, animal, environmental) and Digital Innovation, Nutrition and Food

BBR Pharmacology and Technology
focused on, but not limited to, Pharmacology, Therapeutics and Toxicology, Medicinal Chemistry and Natural Bioactives, Pharmaceutics, Biotechnology and Nanotechnology, Sensors and Analytical Methods

BBR Physiology and Translational Medicine
focused on, but not limited to, Integrative Physiology, Systems and Inter-Systems, Cellular and Molecular Mechanisms, Experimental Models, Disease Mechanisms and Organ and System Dysfunction. Exploration Methodologies and Technologies

Other more applied topics may be considered at the Editor's discretion.

BBR | IBB seeks to promote the practical application of research, placing particular value on interdisciplinary science in open collaboration. We welcome work with translational potential in biomedical and biopharmaceutical issues in the broadest sense, seeking research focused on new insights into structural issues with an impact on health policies and systems, new molecules (natural or designed) with the potential to address major disease burdens, or new mechanistic perspectives on models or processes for studying disease mechanisms with potential impact on diagnosis and/or therapy.

Reproduction Rights and Publication

BBR | IBB is an open access publisher that adopts the CC BY-NC (Creative Commons) distribution license [see more here] and all articles are immediately and permanently accessible, after acceptance, online in open format, free of charge and without any kind of cost or registration.

Competing Interests

Editors do not receive any salary for their work at BBR | IBB. Even so, Editors are required to declare all relevant competing interests and are excluded from participation in the review of any submission for which they have a competing interest.

Publication Fees

BBR | IBB does not charge costs or fees for submission and publication of manuscripts from Portuguese-language speaking authors. For other authors, only an English version is required for submission. However, BBR|IBB does not accept automatic translations (GoogleTranslate, DeepL, others), meaning that the Portuguese version will be a direct responsibility of the Editorial Office. In this case, a fee will be charged to ensure that purpose [+here].

Indexing and Archiving

BBR | IBB is present in several databases  - Portuguese Medical Journals, SciElo UNIVERSIA - Portal das Universidades, LATINDEX, KOSMET Index, Thomson Reuters, PMC, Index Copernicus, Scopus, Google Scholar, REDIB, and mEDRA, among others.

Application to other databases is in progress. 

Ethics and Good Publication Practices 

BBR | IBB takes very seriously all its duties and ethical responsibilities regarding all stages of publication. Our editorial options and policies are detailed  [+aqui].

BBR | IBB is continuously working to promote diversity a concern addressed by a constant (not always well succeeded) search for authors and editors from minor or in-developing communities within the “lusofone” countries. The same awareness has shaped the expansion of our editorial board equity and equality (gender, religious, social, cultural, racial). Our publication priorities and decisions are made keeping in mind the quality, originality and utility of the submitted manuscripts. Nevertheless, we are aware that more inclusive policies are needed to modify recognised imbalances in biomedical publications.   

ALIES

ALIES is a non-profit Open Access publisher supporting all researchers, with emphasis on those from Portuguese speaking countries and communities, to use biomedical and biopharmaceutical knowledge published in BBR | IBB for social progress and science dissemination. Learn more about ALIES here.

Contact

Visit the BBR | IBB contact page for more information [+here].